Clinical trial
Post-Marketing Observational Study on the Effectiveness and Safety of Niaspan® in the Treatment of Lipid Abnormalities in Latin America
NCT01200160 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Marketing Observational Study on the Effectiveness and Safety of Niaspan® in the Treatment of Lipid Abnormalities in Latin America
- Lead sponsor
- Abbott
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- May 31, 2012
- Enrollment
- 128 (actual)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.